Home/Filings/4/0001104659-20-069180
4//SEC Filing

Schranz Jennifer 4

Accession 0001104659-20-069180

CIK 0001641640other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 6:06 AM ET

Size

4.5 KB

Accession

0001104659-20-069180

Insider Transaction Report

Form 4
Period: 2020-05-31
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-05-31$1.14/sh301$343169,046 total

Documents

1 file

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001735382

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 6:06 AM ET
Size
4.5 KB